⸺ Synova Research
GLOW
Research blend combining BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg) in a single 70mg vial — studied for tissue repair, recovery and skin health pathways.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About GLOW
GLOW is a combined research blend pairing two well-studied recovery peptides — BPC-157 and TB-500 — with the copper tripeptide GHK-Cu. Researchers use it to investigate overlapping pathways across soft-tissue repair, angiogenesis, collagen synthesis and skin biology in a single preparation.
⸺ Mechanism of Action
How it works
BPC-157 modulates growth-factor and nitric-oxide signalling involved in tissue protection and repair. TB-500 (a Thymosin Beta-4 fragment) regulates actin dynamics, cell migration and tissue reorganisation. GHK-Cu drives copper-dependent gene expression linked to collagen and elastin synthesis, antioxidant defence and dermal remodelling. Combined, the three peptides target complementary recovery and regenerative pathways in preclinical models.
⸺ Research
Areas of study
Soft-tissue repair
Animal models with BPC-157 and TB-500 describe improved tendon, ligament and muscle repair, with reduced inflammatory markers at injury sites.
Skin and collagen biology
GHK-Cu research shows enhanced collagen and elastin synthesis, accelerated wound closure and improved dermal architecture in preclinical models.
Angiogenesis and recovery
All three peptides have been individually associated with microvascular formation and tissue remodelling — the blend is studied for combined effects on recovery models.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- Blend — see individual components
- Intended use
- Research use only. Contains BPC-157 10mg, TB-500 10mg and GHK-Cu 50mg per vial.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Sterile technique throughout.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.